Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Health economics is a branch of economics which addresses issues related to efficiency, effectiveness, value and behaviour in the production and consumption of health and healthcare. Ensuring that cancer interventions, such as new diagnostic tools, drugs or surgical approaches, are cost-effective and are likely to improve patient health outcomes is central to Oxford health economics research. This is undertaken by working on clinical trials and observational data with clinical and laboratory colleagues. Oxford researchers also carry out interviews and surveys with patients, clinical staff, policy makers and the general public to ascertain their views on cancer care and funding options. A particular area of interest and expertise for health economists in Oxford is the evaluation of novel genomic technologies in cancer.